Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Common Stock | Options Exercise | $126K | +1.4K | +18.63% | $89.70 | 8.91K | Sep 10, 2021 | Direct | |
transaction | MLAB | Common Stock | Sale | -$378K | -1.4K | -15.71% | $270.21 | 7.51K | Sep 10, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Non Qualified Stock Option | Exercise of in-the-money or at-the-money derivative security | $0 | -1.4K | -4.07% | $0.00 | 33K | Sep 10, 2021 | Common Stock | 1.4K | $89.70 | Direct | F1 |
Id | Content |
---|---|
F1 | 1/7 exercisable on each anniversary date of the 04/01/2014 grant date |
F2 | Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 |